Abstract：Objective To observe the therapeutic effect of Tripterygium hypoglaucum Hutch combined with Pimecrolimus in treating patients with facial corticosteroid addiction dermatitis. Methods Seveny-two patients with facial corticosteroid addicted dermatitis were randomly dividecl into the study group (n=36) and the control group (n=36). The subjects in study group were given Tripterygium hypoglaucum Hutch two tabltes orally one time,three times a day and ebastine 10 mg orally one time, a day and topocal pimecrolimus ointment two time a day. The subjects in control group were given ebastine 10 mg orally,one time a day and topical cream made in this hospital, two times a day. The therapeutie effects and adverse effects weve observed after treatment for two and four weeks. Results In the study group,36 cases could be evoluated at the end with a efficacy rate of 67%. In the control group , 36 cases finished the clinical trial with a efficacy rate of 17%.There was a statistically significant difference between the two groups. Conclusions Trpterypium hypoglaucum Hutch combined with pimecrolimus is effective and safe in treating facial corticosteroid addicted dermatitis and deserves to be used wildely.
2013, Vol. 24 
